EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study

Da Yeon Lee, Ji-Hee Ko, Han-Na Jang, Sun Joon Moon, Hye-Mi Kwon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Eun-Jung Rhee

Endocrinology and Metabolism · 31.08.2025 · 40 (4) · 648-652

DOI: 10.3803/enm.2024.2281 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Endocrinology and Metabolism, erschienen am 31.08.2025. Verfasst von Da Yeon Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seou…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Fatty Liver, Metabolic Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the new terminology of metabolic dysfunction-associated steatotic liver disease (MASLD) and MASLD with increased alcohol intake (MetALD) has emerged, the clinical significance of MASLD is increasing. This cross-sectional study analyzed 476,124 health checkup participants (2002–2022) to compare hepatic fibrosis risks across MASLD, MetALD, non-alcoholic fatty liver disease (NAFLD), and metabolic dysfunction-associated fatty liver disease (MAFLD). Steatotic liver was identified via ultrasonography, and fibrosis risk was assessed using aspartate aminotransferase to platelet ratio index and NAFLD fibrosis score. The prevalence of NAFLD, MAFLD, MASLD, and MetALD was 30.1%, 32.3%, 29.8%, and 3.0%, respectively, with a 27.9% overlap among three conditions. Participants with steatotic liver were predominantly male, with higher glucose, lipids, liver enzymes, and homeostasis model assessment of insulin resistance levels. Three disease definitions largely overlapped, with MASLD and NAFLD being very similar, while participants with MAFLD and MetALD showed increased fibrosis risk (clinical trial registration number: 2024-11-050).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisNon-alcoholic Fatty Liver DiseaseFatty LiverMetabolic DiseasesHumansCross-Sectional StudiesMaleFemaleMiddle AgedAdultRepublic of KoreaRisk FactorsPrevalencePrognosisAgedFollow-Up Studies

Stichwörter der Autor:innen

FibrosisKorean adultsMetabolic dysfunction-associated fatty liver diseaseMetabolic dysfunction-associated liver disease with increased alcohol intakeMetabolic dysfunction-associated steatotic liver diseaseNon-alcoholic fatty liver disease

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

Zitieren

APA

Lee, D. Y., Ko, J. H., Jang, H. N., Moon, S. J., Kwon, H. M., Park, S. E., Park, C. Y., Lee, W. Y., Oh, K. W., & Rhee, E. J. (2025). Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study. Endocrinology and Metabolism, 40(4), 648-652. https://doi.org/10.3803/enm.2024.2281

Vancouver

Lee DY, Ko JH, Jang HN, Moon SJ, Kwon HM, Park SE, et al. Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study. Endocrinology and Metabolism. 2025;40(4):648-652. doi:10.3803/enm.2024.2281

BibTeX
@article{Lee2025,
  author = {Lee, Da Yeon and Ko, Ji-Hee and Jang, Han-Na and Moon, Sun Joon and Kwon, Hye-Mi and Park, Se Eun and Park, Cheol-Young and Lee, Won-Young and Oh, Ki-Won and Rhee, Eun-Jung},
  title = {Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study},
  journal = {Endocrinology and Metabolism},
  year = {2025},
  volume = {40},
  number = {4},
  pages = {648--652},
  doi = {10.3803/enm.2024.2281}
}
Kostenlos starten →